Novel Potent and Selective Inhibitors of p90 Ribosomal S6 Kinase Reveal the Heterogeneity of RSK Function in MAPK-Driven CancersIda Aronchik, Anne B. Jefferson, B.A. Appleton et al.|Molecular Cancer Research|2014Cited by 80
Supplementary Table 2 from Novel Potent and Selective Inhibitors of p90 Ribosomal S6 Kinase Reveal the Heterogeneity of RSK Function in MAPK-Driven CancersIda Aronchik, Anne B. Jefferson, B.A. Appleton et al.|Unknown|2023Cited by 0
Supplementary Figures 1 - 4 from Novel Potent and Selective Inhibitors of p90 Ribosomal S6 Kinase Reveal the Heterogeneity of RSK Function in MAPK-Driven CancersIda Aronchik, Anne B. Jefferson, B.A. Appleton et al.|Unknown|2023Cited by 0
Supplementary Table 1 from Novel Potent and Selective Inhibitors of p90 Ribosomal S6 Kinase Reveal the Heterogeneity of RSK Function in MAPK-Driven CancersIda Aronchik, Anne B. Jefferson, B.A. Appleton et al.|Unknown|2023Cited by 0
Supplementary Methods from Novel Potent and Selective Inhibitors of p90 Ribosomal S6 Kinase Reveal the Heterogeneity of RSK Function in MAPK-Driven CancersIda Aronchik, Anne B. Jefferson, B.A. Appleton et al.|Unknown|2023Cited by 0